Chemotherapy combined with cadonilimab (AK104) as neoadjuvant treatment for locally advanced gastric/gastroesophageal junction cancer: A prospective, single-arm, phase II clinical trial

被引：0
|
作者：
Zhang, P. [1 ]
Zhang, W. [1 ]
Liu, X. [2 ]
He, D. [3 ]
Yang, K. [1 ]
Gou, H. [1 ]
Hu, J. [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Gastr Canc Ctr, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1521
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1455P
引用
收藏
页码：S903 / S903
页数：1
相关论文
共 50 条
  • [31] A Single Arm Phase II Study of Neoadjuvant Chemoradiotherapy and AK104 in pMMR/MSS Locally Advanced Rectal Cancer with Positive PD-L1 Expression
    Xiao, W.
    Sun, R.
    Luo, H.
    Wang, Y.
    Zhu, C.
    Cai, P.
    Zhou, X.
    Li, C.
    Zhang, R. X.
    Wu, X.
    Li, L.
    Chen, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E500 - E500
  • [32] Conversion therapy of concurrent chemoradiotherapy combined with tislelizumab for unresectable gastric or gastroesophageal junction adenocarcinoma: A prospective, single-arm, phase II trial
    Liu, D.
    Yang, L.
    Lu, K.
    Zhao, Q.
    Yu, J.
    Liu, Y.
    Chen, Q.
    Liu, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S173 - S173
  • [33] Camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (ESCC): A single-arm, phase II trial
    Gong, Lei
    Yang, Yueyang
    Zhang, Hongdian
    Qiao, Yufeng
    Wang, Haitong
    Ren, Peng
    Tang, Peng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
    Liu, Jun
    Yang, Yang
    Liu, Zhichao
    Fu, Xiaolong
    Cai, Xiaoyue
    Li, Hongxuan
    Zhu, Li
    Shen, Yan
    Zhang, Hong
    Sun, Yifeng
    Chen, Hezhong
    Yu, Bentong
    Zhang, Renquan
    Shao, Jinchen
    Zhang, Ming
    Li, Zhigang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
  • [35] Donafenib as neoadjuvant therapy in locally advanced thyroid cancer: protocol for the DONATHYCA phase II prospective single-arm trial in China
    Yu, Jianhong
    Liu, Hui
    Wu, Yu
    BMJ OPEN, 2024, 14 (05):
  • [36] Perioperative sintilimab combination with SOX for resectable locally advanced gastric/gastroesophageal junction cancer(GC/GEJC): Initial findings of a single-arm phase II trial
    Ding, Xuewei
    Li, Bin
    Xue, Qiang
    Cai, Mingzhi
    Cui, Jingli
    Wang, Baogui
    Ke, Bin
    Zhang, Rupeng
    Liang, Han
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [37] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Yang, Guozhen
    Su, Xiaodong
    Huang, Yuanheng
    Luo, Guangyu
    Wang, Zhiqiang
    Cai, Peiqiang
    Zheng, Yating
    Bei, Ting
    Huang, Mengli
    Bai, Yuezong
    He, Haoqiang
    Xiang, Jin
    Cai, Muyan
    Zhong, Jiudi
    Guo, Qiyu
    Zhang, Xu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [38] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Guozhen Yang
    Xiaodong Su
    Yuanheng Huang
    Guangyu Luo
    Zhiqiang Wang
    Peiqiang Cai
    Yating Zheng
    Ting Bei
    Mengli Huang
    Yuezong Bai
    Haoqiang He
    Jin Xiang
    Muyan Cai
    Jiudi Zhong
    Qiyu Guo
    Xu Zhang
    Journal of Translational Medicine, 21
  • [39] Trilaciclib combined with intraventricular injection chemotherapy in the treatment of advanced NSCLC with leptomeningeal metastasis: A prospective, single-arm, phase II clinical trial
    Fang, S. C.
    Yang, L. F.
    Xu, T.
    Wang, X. Y.
    Cheng, W. W.
    Xu, S.
    Liu, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S861 - S861
  • [40] Efficacy and safety of S-1 plus oxaliplatin combined with apatinib and camrelizumab as neoadjuvant therapy for patients with locally advanced gastric or gastroesophageal junction adenocarcinoma: a protocol for a single-arm phase II trial
    Chang, Chen
    Cai, Zhaolun
    Cheng, Ke
    Shen, Chaoyong
    Zhang, Bo
    Chen, Zhixin
    Yin, Yuan
    Cao, Dan
    UPDATES IN SURGERY, 2025, 77 (01) : 165 - 174
12345